cobicistat 150 MG / darunavir 675 MG Oral Tablet [Prezcobix]
- RxCUI
- 2710426
- RxNorm name
- cobicistat 150 MG / darunavir 675 MG Oral Tablet [Prezcobix]
- Display name
- cobicistat 150 MG / darunavir 675 MG Oral Tablet [Prezcobix]
- Full name
- cobicistat 150 MG / darunavir 675 MG Oral Tablet [Prezcobix]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:10
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PREZCOBIX | DARUNAVIR ETHANOLATE AND COBICISTAT | Janssen Products, LP | 9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f | 2026-02-01 | Warnings, Adverse reactions | 2710426 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f | cobicistat 150 MG / darunavir 675 MG Oral Tablet [Prezcobix] | SBD | 28 | These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use PREZCOBIX ® PED (darunavir and cobicistat) tablets for oral suspension Initial U.S. Approval: 2015 | 20260201 |
| 9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f | Prezcobix 675 MG (as darunavir ethanolate ) / 150 MG Oral Tablet | SY | 28 | These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use PREZCOBIX ® PED (darunavir and cobicistat) tablets for oral suspension Initial U.S. Approval: 2015 | 20260201 |
| 9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f | PREZCOBIX 675 MG / 150 MG Oral Tablet | PSN | 28 | These highlights do not include all the information needed to use PREZCOBIX safely and effectively. See full prescribing information for PREZCOBIX. PREZCOBIX ® (darunavir and cobicistat) tablets, for oral use PREZCOBIX ® PED (darunavir and cobicistat) tablets for oral suspension Initial U.S. Approval: 2015 | 20260201 |